Abnib 250 mg Tablet Substitute

Substitutes of Abnib 250 mg Tablet meet the same safety and efficacy standards as Abnib 250 mg Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Abnib 250 mg Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Abnib 250 mg Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Abnib 250 mg Tablet for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Abnib 250 mg Tablet is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Abnib 250 mg Tablet to its substitute. Always consult your doctor before switching.

Abnib 250 mg Tablet is used to treat breast cancer.

Abnib 250 mg Tablet contains Lapatinib, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.

Inform your doctor whether you have received any other breast cancer treatment. Abnib 250 mg Tablet may cause left ventricular ejection fraction, hypersensitivity reactions, hepatotoxicity, severe diarrhea, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, are pregnant, are planning to become pregnant, or are breastfeeding before taking Abnib 250 mg Tablet .

Hepatotoxicity (liver toxicity) has been reported in clinical studies and postmarketing experience with Abnib 250 mg Tablet . Hepatotoxicity can be fatal, and deaths have been reported. The cause of death is unknown. If you have upper stomach pain, itching, dark urine, clay-coloured faeces, or jaundice (yellowing of the skin or eyes), inform your doctor immediately.

Abnib 250 mg Tablet may cause side effects such as diarrhoea, fatigue, nausea, rash, indigestion, loss of appetite, headache, vomiting, weakness, mouth sores, hair loss, dry skin, myalgia, and allergic reactions. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.

Abnib 250 mg Tablet is an anti-cancer medicine used in the treatment of breast cancer.

Yes, Abnib 250 mg Tablet can be given in combination with other anti-cancer drugs if prescribed by the doctor. Talk to the doctor if you have any concerns.

Swallow the medicine as a whole with a glass of water. Do not chew, crush, or break the medicine. It should be taken one hour before or at least one hour after food.

Drink enough fluids and eat fibre-rich food if you experience diarrhoea. Consult the doctor if the diarrhoea persists or worsens.

Use sunscreen, soap-free cleanser and products that are free from fragrance and are hypoallergenic. Get your skin checked regularly by the doctor during treatment with Abnib 250 mg Tablet .

Before starting Abnib 250 mg Tablet , the doctor may advise heart and liver function tests.

Consult the doctor if you are planning for pregnancy after treatment with Abnib 250 mg Tablet . Use effective contraception during treatment with Abnib 250 mg Tablet and for a week after the last dose.